Benzinga | Aug 13, 2020 04:15PM EDT

Caladrius Biosciences Q2 EPS $0.50 Does Not Compare To $(0.39) Estimate

Caladrius Biosciences (NASDAQ:CLBS) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $(0.39) by 228.21 percent. This is a 202.04 percent increase over losses of $(0.49) per share from the same period last year.